414
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Demographic and Clinical Features of Pediatric Uveitis in Israel

, MD, , MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 43-53 | Received 21 Apr 2018, Accepted 08 Oct 2018, Published online: 17 Oct 2018

REFERENCES

  • Cunningham ET Jr. Uveitis in children. Ocul Immunol Inflamm. 2000;8:251–261. doi:10.1076/ocii.8.4.251.6459.
  • Nagpal A, Leigh JF, Acharya NR. Epidemiology of uveitis in children. Int Ophthalmol Clin. 2008;48:1–7. doi:10.1097/IIO.0b013e31817d740e.
  • Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23:705–717. doi:10.5301/ejo.5000278.
  • Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299–2306. doi:10.1016/j.ophtha.2004.06.014.
  • Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116:1544–1551. doi:10.1016/j.ophtha.2009.05.002.
  • Hettinga YM, Verhagen FH, van Genderen M, de Boer JH. Characteristics of childhood uveitis leading to visual impairment and blindness in the Netherlands. Acta Ophthalmol. 2014;92:798–804. doi:10.1111/aos.2014.92.issue-8.
  • Angeles-Han ST. Quality-of-life metrics in pediatric uveitis. Int Ophthalmol Clin. 2015;55:93–101. doi:10.1097/IIO.0000000000000067.
  • Lonngi M, Aguilar MC, Ríos HA, Aristizábal-Duque CH, Rodríguez FJ, de-la-Torre A. Pediatric uveitis: experience in Colombia. Ocul Immunol Inflamm. 2016;24:410–414. doi:10.3109/09273948.2016.1160129.
  • Päivönsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000;78:84–88.
  • de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879–884.
  • Edelsten C, Reddy MA, Stanford MR, Graham EM. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135:676–680.
  • Kadayifçilar S, Eldem B, Tumer B. Uveitis in childhood. J Pediatr Ophthalmol Strabismus. 2003;40:335–340.
  • Azar D, Martin F. Paediatric uveitis: a Sydney clinic experience. Clin Exp Ophthal. 2004;32:468–471. doi:10.1111/j.1442-9071.2004.00864.x.
  • BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. 2005;89:444–448. doi:10.1136/bjo.2004.050609.
  • Friling R, Kramer M, Snir M, Axer-Siegel R, Weinberger D, Mukamel M. Clinical course and outcome of uveitis in children. J AAPOS. 2005;9:379–382. doi:10.1016/j.jaapos.2005.04.005.
  • Kump LI, Cervantes-Castañeda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112:1287–1292. doi:10.1016/j.ophtha.2005.01.044.
  • Khairallah M, Attia S, Zaouali S, et al. Pattern of childhood-onset uveitis in a referral center in Tunisia, North Africa. Ocul Immunol Inflamm. 2006;14:225–231. doi:10.1080/09273940600732372.
  • Ganesh SK, Bala A, Biswas J, Ahmed AS, Kempen JH. Pattern of pediatric uveitis seen at a tertiary referral center from India. Ocul Immunol Inflamm. 2016;24:402–409. doi:10.3109/09273948.2015.1012298.
  • Gautam N, Singh R, Agarwal A, et al. Pattern of pediatric uveitis at a tertiary referral institute in North India. Ocul Immunol Inflamm. 2016;21:1–7.
  • Keino H, Watanabe T, Taki W, et al. Clinical features of uveitis in children and adolescents at a tertiary referral centre in Tokyo. Br J Ophthalmol. 2017;101:406–410. doi:10.1136/bjophthalmol-2015-308194.
  • Curragh DS, O’Neill M, McAvoy CE, Rooney M, McLoone E. Pediatric uveitis in a well-defined population: improved outcomes with immunosuppressive therapy. Ocul Immunol Inflamm. 2017;27:1–8.
  • Sardar E, Dusser P, Rousseau A, Bodaghi B, Labetoulle M, Koné-Paut I. Retrospective study evaluating treatment decisions and outcomes of childhood uveitis not associated with juvenile idiopathic arthritis. J Pediatr. 2017;186:131–137. doi:10.1016/j.jpeds.2017.03.052.
  • Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. German uveitis in childhood study group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford). 2007;46:1015–1019. doi:10.1093/rheumatology/kem053.
  • Saurenmann RK, Levin AV, Feldman BM, Laxer RM, Schneider R, Silverman ED. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum. 2010;62:1824–1828. doi:10.1002/art.27416.
  • Kalinina AV, Ten CHA, van der Does P, Rothova A, Jh DB. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149:994–999. doi:10.1016/j.ajo.2010.01.016.
  • Calandra S, Gallo MC, Consolaro A, et al. Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis. J Rheumatol. 2014;41:1416–1425. doi:10.3899/jrheum.131494.
  • Tugal-Tutkun I, Quartier P, Bodaghi B. Disease of the year: juvenile idiopathic arthritis-associated uveitis – classification and diagnostic approach. Ocul Immunol Inflamm. 2014;22:56–63. doi:10.3109/09273948.2013.871565.
  • Moradi A, Amin RM, Thorne JE. The role of gender in juvenile idiopathic arthritis-associated uveitis. J Ophthalmol. 2014;2014:461078. Epub. Feb 20.2014. doi:10.1155/2014/461078.
  • Hawkins MJ, Dick AD, Lee RJ, et al. Managing juvenile idiopathic arthritis-associated uveitis. Surv Ophthalmol. 2016;61:197–210. doi:10.1016/j.survophthal.2015.10.005.
  • Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144:812–817. doi:10.1016/j.ajo.2007.08.023.
  • Ozdal PC, Berker N, Tugal-Tutkun I. Pars planitis: epidemiology, clinical characteristics, management and visual prognosis. J Ophthalmic Vis Res. 2015;10:469–480. doi:10.4103/2008-322X.176897.
  • Berker N, Sen E, Elgin U, Atilgan CU, Dursun E, Yilmazbas P. Analysis of clinical features and visual outcomes of pars planitis. Int Ophthalmol. 2017 Apr 7. Epub ahead of print. doi:10.1007/s10792-017-0526-2.
  • Goda C, Kotake S, Ichiishi A, Namba K, Kitaichi N, Ohno S. Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol. 2005;140:637–641. doi:10.1016/j.ajo.2005.04.019.
  • Mackensen F, Smith JR, Rosenbaum JT. Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology. 2007;114:995–999. doi:10.1016/j.ophtha.2007.01.002.
  • Lonngi M, de-la-Torre A. Tubulointerstitial nephritis and uveitis syndrome: Case report and review of the literature. Ocul Immunol Inflamm. 2016;24:415–421.
  • Hettinga YM, de Groot-Mijnes JD, Rothova A, de Boer JH. Infectious involvement in a tertiary center pediatric uveitis cohort. Br J Ophthalmol. 2015;99:103–107. doi:10.1136/bjophthalmol-2014-305367.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516. doi:10.1016/j.ajo.2005.03.057.
  • Petty RE, Southwood TR, Manners P, et al. International League of Associations for rheumatology classification of juvenile idiopathic arthritis: second revision. Edmonton, 2001. J Rheumatol. 2004;31:390–392.
  • Koné-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75:958–964. doi:10.1136/annrheumdis-2015-208491.
  • Herbort CP, Rao NA, Mochizuki M. Members of scientific committee of First International Workshop on ocular sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160–169. doi:10.1080/09273940902818861.
  • Van Assche G, Dignass A, Panes J, et al. European Crohn’s and Colitis Organization (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J Crohns Colitis. 2010;4:7–27. doi:10.1016/j.crohns.2009.12.003.
  • Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302. doi:10.1002/ana.22366.
  • Angeles-Han ST, McCracken C, Yeh S, et al. The Association of Race With Childhood Uveitis. Am J Ophthalmol. 2015;160:919–928.
  • Kuniyoshi K, Hayashi T, Sakuramoto H, et al. New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome. Jpn J Ophthalmol. 2016;60:476–485.
  • Dutta Majumder P, Menia N, Roy R, et al. Uveitis in Patients with Retinitis Pigmentosa: 30 Years' Consecutive Data. Ocul Immunol Inflamm. 2017;29:1–6.
  • Hettinga YM, van Genderen MM, Wieringa W, Ossewaarde-van Norel J, de Boer JH. Retinal Dystrophy in 6 Young Patients Who Presented with Intermediate Uveitis. Ophthalmology. 2016;123:2043–2046.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.